Enabling life science researchers to make groundbreaking discoveries
Exiqon combines leading-edge scientific expertise in gene expression with our proprietary LNA™ technology.
Our products, services and scientific staff enable life science researchers to make groundbreaking discoveries. Moreover, we are addressing the unmet need for a new approach to the diagnosis of cancer.
Announcement No. 23/2008 To OMX Nordic Exchange Copenhagen and the press Copenhagen, April 30, 2008 Exiqon A/S' share capital and total number of voting rights